Method of enhancing lysosomal alpha-Galactosidase A
US-2016346262-A1 · Dec 1, 2016 · US
US9957495B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9957495-B2 |
| Application number | US-201314395049-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 18, 2013 |
| Priority date | Apr 18, 2012 |
| Publication date | May 1, 2018 |
| Grant date | May 1, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure provides a general method for the production of protein variants with a reduced aggregation propensity without affecting the thermodynamic stability of the variant with respect to the wild-type protein.
Opening claim text (preview).
The invention claimed is: 1. A method of producing a reduced aggregating variant of a wild-type protein, which wild-type protein has a high-resolution crystallographic structure available, the wild-type protein comprising at least two beta-aggregation regions, the method comprising: a) determining the at least two beta-aggregation regions in the wild-type protein; b) performing systematic mutation screens of aggregation gatekeeper residues R, K, E, D and P of all amino acids belonging to the determined beta-aggregation regions to generate a list of variant proteins thereof, wherein each variant protein thereof has at least one amino acid position in the at least two beta-aggregation regions changed to either R, K, E, D, or P; c) calculating, for each of the variant proteins, a predicted aggregation score and a predicted change in thermodynamic stability with respect to the wild-type protein; and d) producing, based upon the generated list, a reduced aggregating variant having, at the same time, a maximally reduced predicted aggregation and a maximal preservation of thermodynamic stability, so as to eliminate mutations from the list that thermodynamically destabilize the native structure with the use of an atomic force field. 2. A method of producing a reduced-aggregating variant of a wild-type protein, the wild-type protein having two or more beta-aggregation-regions and further having a high-resolution crystallographic structure available, the method comprising: conducting a systematic mutation screen of aggregation gatekeeper residues R, K, E, D and P of all amino acids belonging to a beta-aggregation region determined to be in the wild-type protein to identify variant proteins of the wild-type protein, wherein each variant protein identified has at least one amino acid position in the beta-aggregation region substituted with either R, K, E, D, or P; calculating, for each of the identified variant proteins, a predicted aggregation score and a predicted change in thermodynamic stability in comparison to the wild-type protein; and synthesizing a variant protein thus calculated to have both a maximally reduced predicted aggregation score and a maximal preservation of thermodynamic stability in comparison to the wild-type protein, so as to eliminate variant proteins that thermodynamically destabilize the wild-type protein's native structure with the use of an atomic force field.
Physics · mapped topic
from coelenteratae, e.g. medusae · CPC title
Chemistry & Metallurgy · mapped topic
acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22) · CPC title
from Bacillus (G) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.